Polypid Ltd (PYPD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.70 +0.15 (+5.88%) 04/15/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.70 unch (unch) 15:55 ET
for Tue, Apr 15th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PYPD | VYNE | CASI | ||
| Company | Polypid Ltd | Vyne Therapeutics Inc | Casi Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.56 | 1.7800 | 2.05 | ||
| High | 2.70 | 1.9298 | 2.06 | ||
| Low | 2.56 | 1.7800 | 1.99 | ||
| Last | 2.70 | 1.8200 | 1.99 | ||
| Change | +0.15 | +0.0700 | -0.11 | ||
| % Change | +5.84% | +4.00% | -5.13% | ||
| Volume | 6,000 | 145,900 | 4,500 | ||
| 20-Day Average Volume | 10,255 | 226,110 | 13,430 | ||
| Previous Close | 2.55 | 1.7500 | 2.10 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.67 | 1.6552 | 2.12 | ||
| 20-Day Raw Stochastic | 58.30% | 74.51% | 17.12% | ||
| 20-Day Relative Strength | 48.12% | 47.36% | 42.39% | ||
| Weighted Alpha | -40.99 | -30.08 | -46.76 | ||
| Today's Opinion | 88% Sell | 72% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 56% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.07% since 04/08/25 | +20.53% since 04/08/25 | -2.45% since 04/08/25 | ||
| Low | 2.33 on 04/09/25 | 1.4600 on 04/10/25 | 1.88 on 04/10/25 | ||
| High | 2.70 on 04/15/25 | 1.9298 on 04/15/25 | 2.37 on 04/09/25 | ||
| 1-Month | |||||
| %Chg | -9.28% since 03/14/25 | -1.62% since 03/14/25 | -10.56% since 03/14/25 | ||
| Low | 2.30 on 04/07/25 | 1.4400 on 04/07/25 | 1.88 on 04/10/25 | ||
| High | 3.08 on 03/18/25 | 1.9500 on 03/25/25 | 2.52 on 03/25/25 | ||
| 3-Month | |||||
| %Chg | -16.70% since 01/15/25 | -34.06% since 01/15/25 | -21.50% since 01/15/25 | ||
| Low | 2.30 on 04/07/25 | 1.4400 on 04/07/25 | 1.88 on 04/10/25 | ||
| High | 3.47 on 01/27/25 | 3.0800 on 01/21/25 | 2.86 on 01/21/25 | ||
| 6-Month | |||||
| %Chg | -20.62% since 10/15/24 | -9.00% since 10/15/24 | -64.34% since 10/15/24 | ||
| Low | 2.30 on 04/07/25 | 1.4400 on 04/07/25 | 1.88 on 04/10/25 | ||
| High | 3.85 on 12/24/24 | 4.3000 on 01/08/25 | 6.50 on 10/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 25,987 | 26,618 | 25,797 | ||
| Shares Outstanding, K | 10,191 | 15,210 | 12,299 | ||
| Annual Sales | 0 | 500,000 | 28,540,000 | ||
| Annual Net Income | -29,020,000 | -39,830,000 | -39,260,000 | ||
| Last Quarter Sales | 0 | 80,000 | 13,360,000 | ||
| Last Quarter Net Income | -8,520,000 | -12,020,000 | -14,370,000 | ||
| 60-Month Beta | 1.28 | 1.37 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.13 on 02/12/25 | -0.28 on 03/06/25 | -0.79 on 03/31/25 | ||
| Latest Earnings Date | 05/14/25 | 05/08/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||